Preoperative Neutrophil-lymphocyte Ratio as a Predictor of Overall Survival in Patients with Localized Renal Cell Carcinoma
Urology Journal,
Vol. 17 No. 1 (2020),
26 Bahman 2020
,
Page 30-35
https://doi.org/10.22037/uj.v17i1.4541
Abstract
Purpose: The neutrophil-to-lymphocyte ratio (NLR), as an indicator of the systemic inflammatory response, predicts adverse outcomes in many malignancies. We investigated its prognostic significance in patients with non-metastatic renal cell carcinoma.Materials and Methods: We retrospectively evaluated data of 196 consecutive non-metastatic RCC patients who underwent radical or partial nephrectomy between 2010 and 2012 at a single center. Overall survival (OS) was assessed using the Kaplan-Meier method and compared using the log-rank test. We applied univariate and multivariate Cox regression models to evaluate the prognostic value of dichotomized NLR for OS.
Results: At a median follow up of 68 months, high NLR (? 2,69) correlated with worse survival outcome (P = .006 in log-rank test) and higher tumor stage (P = .035). Univariate and multivariate analysis identified elevated NLR (P = .039), as well as age (P = .002), high Fuhrmann grade (P = .002) and high pathologic T stage (P < .001), as significantly associated with overall survival.
Conclusion: In our cohort, an elevated neutrophil-to-lymphocyte ratio is significantly associated with worse OS on univariate and multivariate analysis. Consequently, the NLR is an easily acquired biomarker, which may be useful in pretreatment patient risk stratification.
How to Cite
References
European Network of Cancer Registries: Eurocim version 4.0. 2001: Lyon, France.
Lindblad, P. Epidemiology of renal cell carcinoma. Scand J Surg, 2004. 93: 88.
Patard JJ, Rodriguez A, Rioux-Leclercq N, Guillé F, Lobel B. Prognostic significance of the mode of detection in renal tumours. BJU Int. 2002 Sep;90(4):358-63.
Kato M, Suzuki T, Suzuki Y, Terasawa Y, Sasano H, Arai Y.
Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol, 2004. 172: 863-6.
KE-HUNG TSUI,OLEG SHVARTS,ROBERT B. SMITH,ROBERT FIGLIN,JEAN B. de KERNION,ARIE BELLDEGRUN
Renal cell carcinoma: prognostic significance of incidentally detected tumors.
J Urol, 2000. 163: 426-430.
Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, McKiernan J, Russo P. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol, 2005. 173: 48-51.
Patard JJ, Kim HL, Lam JS, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004 Aug 15;22(16):3316-22..
Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007 Apr 10;25(11):1316-22.
Zigeuner R, Hutterer G, Chromecki T, et al. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Eur Urol. 2010 Jan;57(1):102-9.
Graeme J.K. Guthrie, Kellie A. Charles, Campbell S.D. Roxburgh, Paul G. Horgan, Donald C. McMillan, Stephen J. Clarke. The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30.
Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6. 1:149–163
Acharya, S., Rai, P., Hallikeri, K., Anehosur, V. and Kale, J. (2017), Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma. J Invest Clin Dent, 8: n/a, e12219.
You Luo; Dong-Li She; Hu Xiong; Sheng-Jun Fu; Li Yang. Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors A Systematic Review and Meta-Analysis. Medicine, 2015 Oct; 94(40): e1670.
Al-Ali BM, Ress AL, Gerger A, Pichler M. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2012 Sep; 32(9):3727-32
Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. Engl J Med. 2012 Mar 8; 366(10):883-892.
Kim SC, Sun KH, Choi DH, et al. Prediction of Long-Term Mortality Based on Neutrophil-Lymphocyte Ratio After Percutaneous Coronary Intervention. Am J Med Sci. 2016 May;351(5):467-72.
Quiros-Roldan E, Raffetti E, Donato F, et al. Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study. PLoS One. 2016 May 5;11(5):e0154900.
Boissier R, Campagna J, Branger N, Karsenty G, Lechevallier E. The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review. Urol Oncol. 2017 Apr;35(4):135-141.
Fox, P., Hudson, M., Brown, C. et al. Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer. 2013; 109: 147–153
M Pichler, G C Hutterer, C Stoeckigt, et al. Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer. 2013 Mar 5; 108(4): 901–907.
Yoshio Ohno, Jun Nakashima, Makoto Ohori, Tadashi Hatano, Masaaki Tachibana. Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Recurrence in Patients With Nonmetastatic Renal Cell Carcinoma. J Urol. Volume 184, Issue 3, September 2010, Pages 873-878
Leibovich, B. C., Blute, M. L., Cheville, J. C., et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma. Cancer, 97: 1663–1671.
Boyd R. Viers, Robert Houston Thompson, Stephen A. Boorjian, Christine M. Lohse, Bradley C. Leibovich, Matthew K. Tollefson. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy. Urol Oncol. Volume 32, Issue 8, November 2014, Pages 1277-1284
Wassim M. Bazzi, Amy L. Tin, Daniel D. Sjoberg, Melanie Bernstein, Paul Russo. The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma. Can J Urol. (2016). 23. 8151-8154.
Hanahan D, Weinberg RA Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646-74.
Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006 Apr;4(4):221-33
Motomura, T., Shirabe, K., Mano, Y., et al. Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013; 58:58–64
Kantola, T., Klintrup, K., Vayrynen, J.P., et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer. 2012; 107: 1729–1736
- Abstract Viewed: 858 times
- pdf/4541 Downloaded: 332 times